Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staging and prognostic factors in soft tissue sarcoma.

P W Pisters1, R E Pollock

  • 1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

Seminars in Radiation Oncology
|October 12, 1999
PubMed
Summary

Understanding soft tissue sarcoma prognosis has advanced, improving identification of high-risk patients using clinicopathologic data. Molecular factors also show independent prognostic significance for this cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis.

Clinical & experimental pharmacology·2017
Same author

Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients.

Annals of surgical oncology·2009
Same author

Outcome of locally recurrent and metastatic angiosarcoma.

Annals of surgical oncology·2009
Same author

Reliable establishment of human sarcoma xenografts in the nude rat.

Sarcoma·2008

Area of Science:

  • Oncology
  • Pathology

Background:

  • Recent advances have significantly improved the understanding of prognostic factors for soft tissue sarcoma.
  • There is an enhanced ability to identify patients at high risk for recurrent disease based on initial clinicopathologic data.

Purpose of the Study:

  • To review the updated American Joint Committee on Cancer staging system for soft tissue sarcoma.
  • To summarize data on traditional clinicopathologic and molecular prognostic factors.

Main Methods:

  • Review of recent literature on soft tissue sarcoma.
  • Analysis of clinicopathologic and molecular prognostic factors.
  • Examination of the updated American Joint Committee on Cancer staging system.

Main Results:

Related Experiment Videos

  • Improved recognition of high-risk patients at initial presentation.
  • Elucidation of specific molecular factors with independent prognostic significance.
  • Updated staging system provides a refined framework for prognosis.

Conclusions:

  • Clinicopathologic and molecular factors are crucial for soft tissue sarcoma prognosis.
  • Accurate risk stratification aids in patient management and treatment planning.
  • The updated staging system enhances prognostic accuracy.